Detalles de la búsqueda
1.
Validation of the BCIS CHIP Score in chronic total occlusion percutaneous coronary intervention.
Catheter Cardiovasc Interv
; 103(6): 856-862, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38629740
2.
Retrograde chronic total occlusion percutaneous coronary intervention via ipsilateral collaterals.
Catheter Cardiovasc Interv
; 103(6): 863-872, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38563074
3.
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial.
Lancet
; 399(10333): 1401-1410, 2022 04 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35390320
4.
Impact of lesion length on the outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
Catheter Cardiovasc Interv
; 101(4): 747-755, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36740236
5.
Same day discharge versus overnight observation following chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
Catheter Cardiovasc Interv
; 101(6): 1028-1035, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36960766
6.
Aortocoronary dissection during percutaneous coronary interventions for chronic total occlusion: Insights from the PROGRESS-CTO registry.
Catheter Cardiovasc Interv
; 102(1): 56-63, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37172209
7.
Balloon-assisted subintimal entry (BASE) in chronic total occlusion percutaneous coronary interventions.
Catheter Cardiovasc Interv
; 102(5): 834-843, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37676010
8.
Impact of preprocedural anemia on in-hospital and follow-up outcomes of chronic total occlusion percutaneous coronary intervention.
Catheter Cardiovasc Interv
; 102(5): 857-863, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37681964
9.
External validation of the PROGRESS-CTO perforation risk score: Individual patient data pooled analysis of three registries.
Catheter Cardiovasc Interv
; 2023 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36617391
10.
Incidence, mechanisms, treatment, and outcomes of donor vessel injury during percutaneous coronary interventions for chronic total occlusion.
Catheter Cardiovasc Interv
; 102(4): 585-593, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37560823
11.
Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear study.
Catheter Cardiovasc Interv
; 99(3): 583-592, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34478233
12.
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial.
Lancet
; 395(10234): 1444-1451, 2020 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32234534
13.
Equipment utilization in chronic total occlusion percutaneous coronary interventions: Insights from the PROGRESS-CTO registry.
Catheter Cardiovasc Interv
; 97(4): 658-667, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32597031
14.
SCAI publications committee manual of standard operating procedures.
Catheter Cardiovasc Interv
; 96(1): 145-155, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32061033
15.
Outcomes of subintimal plaque modification in chronic total occlusion percutaneous coronary intervention.
Catheter Cardiovasc Interv
; 96(5): 1029-1035, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31797507
16.
Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial.
Lancet
; 392(10157): 1530-1540, 2018 10 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-30266412
17.
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial.
Lancet
; 391(10137): 2346-2355, 2018 06 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29803589
18.
SCAI/ACVP expert consensus statement on cardiovascular catheterization laboratory economics: If the cath lab is your home you should understand its finances: This statement was endorsed by the Alliance of Cardiovascular Professionals (ACVP) in April 2019.
Catheter Cardiovasc Interv
; 94(1): 123-135, 2019 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31104353
19.
First and recurrent events after percutaneous coronary intervention: implications for survival analyses.
Scand Cardiovasc J
; 53(6): 299-304, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31315473
20.
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial.
Lancet
; 390(10108): 2160-2170, 2017 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28859944